Bioherent
PrivateLast Round
Early Funding
Jul 17, 2025
Total Funding Raised
$5.59M
Company Overview
Bioherent is a deep-tech company that develops next-generation in-vitro diagnostic (IVD) solutions using silicon photonics and proprietary surface chemistry for drug allergy testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioherent Comparables
Compare Bioherent with similar companies based on industry and business-model similarity.
Bioherent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 17, 2025 | ||||
| Seed | Feb 25, 2022 |
Key People
Founding team and executive leadership
Bioherent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDTI Innvierte | Early Funding |
| Axon Partners Group | Early Funding |
| Center for Technological Development and Innovation | Seed |
| Bullnet Capital | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 2823% MoM, from 30 to 877.
- Nov 7, 2025
Monthly visitors grew 95% MoM.
Bioherent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bioherent's valuation, stock price, and market status.
Is Bioherent a public or private company?
Bioherent is a private company.
What is the current stock price of Bioherent?
Bioherent is a private company with no public stock price. No recent secondary market data is available.
How much is Bioherent worth (valuation)?
Valuation information for Bioherent is not publicly available.
Can I buy Bioherent stock?
Bioherent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bioherent's last funding round?
Bioherent's most recent funding round was Early Funding on July 17, 2025.
Who are the main investors in Bioherent?
Key investors in Bioherent include Bullnet Capital.
Will Bioherent IPO soon?
No public IPO plans have been announced for Bioherent.
How can I track Bioherent secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioherent's secondary market activity and sign up for updates.